ROS, E. O. (2021). The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited. Reactive Oxygen Species, 11, n7–n8. https://doi.org/10.20455/ros.2021.n.807